The global fertility supplement market size is predicted to reach $3.52B by 2030, according to a new report by Grand View Research, expanding at a CAGR of 7.9% from 2022 to 2030. The decline in fertility rates caused by increased consumption of cigarettes, alcohol, and caffeine is expected to fuel demand for fertility supplements in the coming years.
By ingredient, the natural segment is predicted to expand at the fastest CAGR of 10.0% in the forecast period owing to changing consumer preferences for using products that contain herbal and organic ingredients rather than synthetic ingredients.
By product, capsules and tablets held a sizeable revenue share in 2021 on account of ease of consumption and convenience for consumers.
By distribution channel, the over-the-counter (OTC) segment led the market with a revenue share of over 75.0% in 2021 owing to the accessibility and convenient purchasing of such products.
Asia Pacific is anticipated to witness the fastest growth in the forecast period owing to rising consumption of supplements and growing retail chains in India, Japan, and China.
The market for fertility supplements is highly competitive. A number of strategic initiatives, such as mergers and acquisitions, product innovation, and portfolio expansion, have been favored by the dominant market players.